Funding of contraceptive research
This paper presents data on financial support of the reproductive sciences and contraceptive development assembled in the course of a two-year review of research funding by an international group of scientists and scientific administrators. Until the mid-1960s, research in reproduction was supported primarily by university budgets, philanthropic funds, and pharmaceutical firms. This research received only an insignificant share of the government support of biomedical research which grew rapidly following World War II. Establishment in the U. S. of the National Institute of Child Health and Human Development in 1963 ushered in a decade of rapid growth of government funding for the field. Expressed in terms of constant dollars (1970 = 100), total world support from all sources reached a peak of $100 million in 1972 and 1973 and declined in 1974 and 1975. Over the past decade, governments have become the major source of support for the field, as the proportion contributed by private foundations and pharmaceutical firms has declined. While the major impetus for recent support of the reproductive sciences has stemmed from concern with world population growth, and hence is part of an effort to find improved methods of fertility control, fundamental research has received nearly 60% of the funding throughout the past decade while applied contraceptive research has received about 30 %. As pharmaceutical firm expenditures have become a smaller proportion of the total funds involved in contraceptive development, they have been supplemented by missionoriented programmes in the public sector devoted to this effort.